Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 48 citing Caporali: Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind,.... (0.09 sec) 

Polymyalgia rheumatica and giant-cell arteritis

- nejm.org
C Salvarani, F Cantini, GG Hunder - The Lancet, 2008 - Elsevier
Polymyalgia rheumatica and giant-cell arteritis are closely related disorders
that affect people of middle age and older. They frequently occur together. Both
are syndromes of unknown cause, but genetic and environmental factors might ...
Cited by 391 - Related articles - BL Direct - All 28 versions

Polymyalgia rheumatica and giant cell arteritis

- nih.gov [PDF] 
LA Healey, KR Wilske - Western Journal of Medicine, 1984 - pubmedcentral.nih.gov
Polymyalgia rheumatica is a relatively common syndrome of older patients, mostly
white, manifested by aching and morning stiffness of the pelvic and shoulder
girdles and ac- companied by a rapid erythrocyte sedimentation rate. The ...
Cited by 54 - Related articles - BL Direct - All 10 versions

[PDF] Adjunctive Methotrexate for Treatment of Giant Cell Arteritis


AD Mahr, JA Jover, RF Spiera, C Hernández- … - Arthritis & Rheumatism, 2007 - assets0.pubget.com
Objective. To reevaluate the efficacy and safety of adjunctive low-dose
methotrexate (MTX) in giant cell arteritis (GCA). Methods. An individual patient
data meta- analysis of 3 randomized placebo-controlled trials in patients ...
Cited by 44 - Related articles - View as HTML - BL Direct - All 5 versions

Infliximab plus prednisone or placebo plus prednisone for the initial treatment of …

- annals.org [PDF] 
C Salvarani, PL Macchioni, C Manzini, G … - Annals of internal medicine, 2007 - Am Coll Physicians
Background: A reliable alternative to steroids for treating poly- myalgia
rheumatica has not yet been identified. Although infliximab has been used
occasionally in steroid-resistant cases, its efficacy has not been ...
Cited by 44 - Related articles - BL Direct - All 7 versions

Multinational evidence-based recommendations for the use of methotrexate in rheumatic …

- nih.gov
K Visser, W Katchamart, E Loza, JA Martinez … - British Medical Journal, 2009 - ard.bmj.com
Methods: 751 rheumatologists from 17 countries participated in the 3E (Evidence,
Expertise, Exchange) Initiative of 2007–8 consisting of three separate rounds
of discussions and Delphi votes. Ten clinical questions concerning the use ...
Cited by 24 - Related articles - All 8 versions

Corticosteroid-induced clinical adverse events: frequency, risk factors and patient's opinion.


L Fardet, A Flahault, A Kettaneh, KP Tiev, T … - British Journal of Dermatology, 2007 - pt.wkhealth.com
Results: Eighty-eight patients were enrolled and 80 were monitored for at least
3 months (women 76%; mean age 59·1 ± 18·7 years; giant cell arteritis 39%;
mean baseline prednisone dosage 54 ± 17 mg day -1 ). Lipodystrophy was the ...
Cited by 21 - Related articles - BL Direct - All 7 versions

Developing classification criteria for polymyalgia rheumatica: comparison of views from an …

- asmn.re.it [PDF] 
B Dasgupta, C Salvarani, M Schirmer, C … - Journal of Rheumatology, 2008 - jrheum.org
Personal non-commercial use only. The Journal of Rheumatology Copyright © 2008.
All rights reserved. ... Rheumatica: Comparison of Views from an Expert ...
Panel and Wider Survey BHASKAR DASGUPTA, CARLO SALVARANI, MICHAEL SCHIRMER, ...
Cited by 15 - Related articles - BL Direct - All 7 versions

Novel therapeutic strategies for large vessel vasculitis


CL Koening, CA Langford - Rheumatic Disease Clinics of North America, 2006 - Elsevier
GCA preferentially involves branches of the external and internal carotid
arteries. It has an annual incidence of 18.8 per 100,000 in the United States
and a predilection for persons of Northern European origin [1]. Twenty-five ...
Cited by 12 - Related articles - All 11 versions

Vasculitis in the geriatric population

- grg-bs.it [PDF] 
CA Langford - Rheumatic Disease Clinics of NOrth America, 2007 - Elsevier
Vasculitis represents an uncommon but important group of disease entities that
may affect older patients. The most common vasculitic disease in humans in giant
cell arteritis, a disease process seen almost exclusively in patients older ...
Cited by 11 - Related articles - All 22 versions

Giant cell arteritis


SC Carroll, BJ Gaskin, HV Danesh-Meyer - Clinical &# 38; Experimental Ophthalmology, 2006 - ingentaconnect.com
Giant cell arteritis (GCA) is an immune-mediated vasculitis, affecting medium-
to large-sized arteries, in individuals over the age of 50 years. Visual loss is
a frequent complication of GCA, and once it occurs it tends to be both ...
Cited by 11 - Related articles - BL Direct - All 2 versions


Result Page: 

1

2

3

4

5

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google